PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy Biotech Investing
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader and Company Panel Biotech Investing
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program Biotech Investing
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia Biotech Investing
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium Biotech Investing
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference Biotech Investing
ROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City Biotech Investing
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments Biotech Investing
PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate over US$25 Million in Milestone and Profit-Sharing Payments Biotech Investing
